Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability

Journal of Pharmaceutical Sciences

Volumn 85, Issue 11, 1996, Pages 1170-1173

  Davies, Neal M ^a,b   Wright, Matthew R ^a,c   Russell, Anthony S ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDETATE CHROMIUM CR 51; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG POTENCY; ENANTIOMER; GASTROINTESTINAL TOXICITY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTAGLANDIN SYNTHESIS INHIBITION; RACEMIC MIXTURE; RAT; STEREOCHEMISTRY; URINARY EXCRETION;

EID: 0029807820     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960276y     Document Type: Article

References (30)

1. Rainsford, K. D. In Side-effects of anti-inflammatory drugs; Rainsford, K. D., Velo, G. P., Eds.; MTP Press: Norwell, MA, 1985; Vol. 2, pp 343-362.
2. Fries, J. F. J. Musculoskel. Med. 1991, 8, 21-28.
3. Hutt, A. J.; Caldwell, J. J. Pharm. Pharmacol. 1983, 35, 693-704.
4. Brune, K.; Beck, W. S.; Geisslinger, G.; Menzel-Soglowek, S.; Peskar, B. M.; Peskar, B. A. Experientia 1991, 47, 257.
5. Cox, P. G. F.; Moons, W. M.; Russel, F. G. M.; van Ginneken, C. A. M. Br. J. Pharmacol. 1991, 103, 1542-1546.
6. Villaneuva, M.; Heckenberger, R.; Strobach, H.; Palmer, M.; Schrör, K. Br. J. Clin. Pharmacol. 1983, 35, 235-242.
7. Wright, M. R.; Davies, N. M.; Jamali, F. J. Pharm. Sci. 1994, 83, 911-912
8. Jamali, F.; Mehvar, R.; Pasutto, F. M. J. Pharm. Sci. 1989, 78, 695-715.
9. Caldwell, J.; Hutt, A. J.; Fournel-Gigleux, S. Biochem. Pharmacol. 1988, 37, 105-114.
10. Ariens, E. J. Eur. J. Clin. Pharmacol. 1984, 26, 663-669.
11. Knihinicki, R. D.; Day, R. O.; Graham, G. G.; Williams, K. M. Chirality 1990, 2, 134-140.
12. Davies, N. M.; Wright, M. R.; Jamali, F. Pharm. Res. 1994, 11, 1564-1569.
13. Ford, J.; Martin, S. W.; Houston, J. B. J. Pharmacol. Toxicol. Methods 1995, 34, 9-16.
14. Bjarnason, I.; Peters, T. J.; Levi, A. J. Dig. Dis. 1986, 4, 83-92.
15. Aabakken, L. Aliment. Pharmacol. Ther. 1992, 6, 143-162.
16. Wright, M. R.; Sattari, S.; Brocks, D. R.; Jamali, F. J. Chromatogr. 1992, 583, 259-265.
17. Palylyk, E. L.; Jamali, F. J. Chromatogr. 1991, 568, 187-196.
18. Berry, B. W.; Jamali, F. Pharm. Res. 1988, 5, 123-125.
19. Foster, R. T.; Jamali, F. Pharm. Res. 1987, 4, 623-626.
20. Jamali, F.; Berry, B. W. Eur. J. Drug Metab. Pharmacokinet. 1990, 15, A402.
21. Metzler, C. M.; Weiner, D. L. PCNONLIN-Version 4.1; Statistical Consultants, Inc. Lexington, KY, 1992.
22. Jamali, F.; Berry, B. W.; Tehrani, M. R.; Russell, A. S. J. Pharm. Sci. 1987, 77, 666-669.
23. Kantor, H. S.; Hampton, M. Nature 1978, 276, 841-842.
24. Milks, L. C.; Conyers, G. P.; Cramer, E. B. J. Cell Biol. 1986, 103, 2729-2738.
25. Kubes, P. Am. J. Physiol. 1992, 262, G1138-G1142.
26. Winter, M. C.; Peterson, M. W.; Shasby, D. M. Am. J. Respir. Cell Mol. Biol. 1991, 4, 470-477.
27. Iwaka, S.; He, X.; Hashimoto, S.; Volland, C.; Benet, L. Z.; Lin, E. T. Drug. Metab. Dispos. 1981, 19, 717-718.
28. Menzel, S.; Beck, W. S.; Brune, K.; Geisslinger, G. Chirality 1993, 5, 422-427.
29. McCracken, J. D.; Wechter, W. J.; Quiggle, D.; Liu, Y. J.; Chase, R.; Mineyama, Y. J. Clin. Pharmacol. 1996, 36, 489.
30. Wechter, W. J.; Bigornia, A. E.; Murray, E. D.; Levine, B. M.; Young, J. M. Chirality 1993, 5, 492-494.